Michael Hale
Impact in
- Virology top 10%
- HIV Research and Treatment
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
Papers in
-
- Cancer therapeutics and mechanisms 3
- Melanoma and MAPK Pathways 2
-
- Synthetic Organic Chemistry Methods 3
- Co-authors
- Amir H. Hoveyda (3 shared papers)Gregory S. Bisacchi (1 shared paper)Edward A. Dennis (1 shared paper)Eric S. Furfine (3 shared papers)Andrew Spaltenstein (3 shared papers)Harry H. Wasserman (1 shared paper)Kilian W. Conde‐Frieboes (1 shared paper)Christopher Baker (2 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (3 papers)ACS Medicinal Chemistry Letters (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)The Journal of Organic Chemistry (2 papers)The FASEB Journal (1 paper)
- Partner nations
- United StatesUnited KingdomIndia
In The Last Decade
Michael Hale
17 papers receiving 618 citations
Peers
Comparison fields: 5 of 85
- Virology 75
- Molecular Medicine 49
- Organic Chemistry 240
- Infectious Diseases 148
- Molecular Biology 329
Countries citing papers authored by Michael Hale
This map shows the geographic impact of Michael Hale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Hale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Hale more than expected).
Fields of papers citing papers by Michael Hale
This network shows the impact of papers produced by Michael Hale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Hale. The network helps show where Michael Hale may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Hale, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 116 | |
| 2 | 2007 | 98 | |
| 3 | 1996 | 78 | |
| 4 | 2004 | 73 | |
| 5 | 2006 | 70 | |
| 6 | 1992 | 47 | |
| 7 | 2016 | 39 | |
| 8 | 2007 | 26 | |
| 9 | 2014 | 21 | |
| 10 | 2013 | 20 | |
| 11 | 2024 | 16 | |
| 12 | 1994 | 14 | |
| 13 | 1996 | 14 | |
| 14 | 2015 | 9 | |
| 15 | 2014 | 6 | |
| 16 | 2024 | 2 | |
| 17 | 2015 | 1 | |
| 18 | 2024 | 0 |
About Michael Hale
Michael Hale is a scholar working on Molecular Biology, Organic Chemistry, Pharmacology, Molecular Medicine and Infectious Diseases, having authored 18 papers that have together received 650 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (4 papers), HIV Research and Treatment (3 papers), Cancer therapeutics and mechanisms (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Synthetic Organic Chemistry Methods (3 papers), HIV/AIDS drug development and treatment (3 papers), Melanoma and MAPK Pathways (2 papers) and Bacterial Genetics and Biotechnology (2 papers). The work is most often cited by research in Virology (75 citations), Molecular Medicine (49 citations), Organic Chemistry (240 citations), Infectious Diseases (148 citations) and Molecular Biology (329 citations). Michael Hale has collaborated with scholars based in United States, United Kingdom and India. Frequent co-authors include Amir H. Hoveyda, Gregory S. Bisacchi, Edward A. Dennis, Eric S. Furfine, Andrew Spaltenstein, Harry H. Wasserman, Kilian W. Conde‐Frieboes, Christopher Baker, Laure J. Reynolds and Roger D. Tung. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, ACS Medicinal Chemistry Letters, Antimicrobial Agents and Chemotherapy, The Journal of Organic Chemistry and The FASEB Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.